Login

A conversation with William Ma, Global CIO of GROW Investment Group, hosted by Alvin Fan, CEO of OP Investment Management, filmed on 28 Nov 2023. 00:10:00

Share On Facebook Share On Twitter

Alvin Fan, CEO of OP Investment Management

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Clayton Allen, SVP at Height Capital Markets, discusses trade and economic issues.
00:10:00
Navigating Market Uncertainty: Risk Assessment and Long-Term Investment Strategies
00:10:00
Perspectives from Activist Investor Bill Ackman
00:10:00
BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Managing Derector Eric Yong , Crest Builder Holdings Berhad
00:10:00
In a conversation with Andy Headley of Veritas Asset Management, the potential of UK equities in the pharmaceutical sector is explored.
00:10:00
serving a large addressable market by the potential|Gary Benitt,Managing Partner,Social Leverage
00:10:00
"November 2022 Investment Committee Update with John Shanley, CFP®, and Dan Ballou, CFP® | Connecticut Wealth Management"
00:10:00
Disaster Planning Webinar: Essential Steps for Natural Disaster Preparedness | Derek Hensley - Wealth Advisor of Sound Stewardship, LLC
00:10:00
Professor Justin Jackson on Literary Approach to the Bible|Justin Jackson,Professor,Hillsdale College
00:10:00
Championing Communication and Sustainability in Private Equity | Elin Ljung - Director of Communication and Sustainability, Nordic Capital
00:10:00
High-Speed Data in Non-Terrestrial Applications | Richard Gibbs , Chief Executive Officer of Filtronic Plc

© 2026 Nehu